Halfon P - Search Results

1

Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation.

Halfon P, Berger P, Khiri H, Martineau A, Pénaranda G, Merlin M, Faucher C. Halfon P, et al. J Med Virol. 2011 Mar;83(3):490-5. doi: 10.1002/jmv.21996. J Med Virol. 2011. PMID: 21264870

2

Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients.

Mohamed S, Ravet S, Camus C, Khiri H, Olive D, Halfon P. Mohamed S, et al. Among authors: halfon p. J Med Virol. 2014 Mar;86(3):394-403. doi: 10.1002/jmv.23853. Epub 2013 Nov 19. J Med Virol. 2014. PMID: 24248806

3

Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.

Halfon P, Pénaranda G, Bourlière M, Khiri H, Masseyeff MF, Ouzan D. Halfon P, et al. J Med Virol. 2006 Feb;78(2):208-15. doi: 10.1002/jmv.20529. J Med Virol. 2006. PMID: 16372298 Clinical Trial.

4

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.

Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, Blanc B. Halfon P, et al. J Clin Virol. 2010 Feb;47(2):177-81. doi: 10.1016/j.jcv.2009.11.011. Epub 2009 Dec 22. J Clin Virol. 2010. PMID: 20022804

5

Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.

Halfon P, Benmoura D, Agostini A, Khiri H, Penaranda G, Martineau A, Blanc B. Halfon P, et al. J Clin Virol. 2010 Aug;48(4):246-50. doi: 10.1016/j.jcv.2010.05.008. Epub 2010 Jun 11. J Clin Virol. 2010. PMID: 20541966

6

Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice.

Halfon P, Penaranda G, Mohamed S, Camus C, Khiri H. Halfon P, et al. Eur J Gastroenterol Hepatol. 2015 May;27(5):557-60. doi: 10.1097/MEG.0000000000000326. Eur J Gastroenterol Hepatol. 2015. PMID: 25822864

7

Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure.

Mohamed S, Bourliere M, Benali S, Oules V, Castellani P, Khiri H, Camus C, Penaranda G, Chiche L, Gonzalez D, Sayada C, Olive D, Halfon P. Mohamed S, et al. Among authors: halfon p. J Clin Virol. 2016 May;78:36-43. doi: 10.1016/j.jcv.2016.02.022. Epub 2016 Feb 26. J Clin Virol. 2016. PMID: 26971166

8

An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients.

Halfon P, Penaranda G, Khiri H, Garcia V, Drouet H, Philibert P, Psomas C, Delord M, Retornaz F, Charpin C, Gonzales T, Pegliasco H, Allardet-Servent J. Halfon P, et al. PLoS One. 2021 Sep 23;16(9):e0257817. doi: 10.1371/journal.pone.0257817. eCollection 2021. PLoS One. 2021. PMID: 34555117 Free PMC article.

9

Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.

Halfon P, Khiri H, Tran A, Pénaranda G, Courcambeck J, Joly H, Ouzan D. Halfon P, et al. Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1067-71. doi: 10.1097/01.meg.0000085472.12407.49. Eur J Gastroenterol Hepatol. 2003. PMID: 14501613

10

Medically assisted procreation and transmission of hepatitis C virus: absence of HCV RNA in purified sperm fraction in HIV co-infected patients.

Halfon P, Giorgetti C, Bourlière M, Chabert-Orsoni V, Khiri H, Pénaranda G, Chincholle JM, Gallais H, Ravaux I, Moreau J, Gastaud JA, Roulier R. Halfon P, et al. AIDS. 2006 Jan 9;20(2):241-6. doi: 10.1097/01.aids.0000200532.56490.fe. AIDS. 2006. PMID: 16511417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters